Epstein Secrets

mbers states are struggling to get their vaccine rollout going at top speed." The AP says "the hardening of its position came days after it accused AstraZeneca of failing to guarantee the delivery of coronavirus vaccines without a valid explanation. It also had expressed displeasure over vaccine delivery de

ther settings - like indoor dining, bars or poorly ventilated gyms - in order to keep infection rates low in the community at large, researchers at the Centers for Disease Control and Prevention wrote in the journal JAMA." Reuters (1/26, Chander) reports the CDC researchers, writing in the Journal of the American Medical Association, "said

accine." CBS (Tyab) added, "The Serum Institute of India is the world's largest manufacturer of vaccines and has been tapped by pharmaceutical giant AstraZeneca to produce over a billion doses of the vaccine being trialed by Oxford University." If the trials are successful, "there is still serious concerns

loggerheads at this moment." The New York Post (7/19, Moore, 4.57M) points out Trump was "asked about comments by Robert Redfield, the director of the Centers for Disease Control and Prevention, that COVID- 19 could make this coming fall and winter the 'most difficult times that we've experienced in American public health." Said Trump, "I d

on within just a few days." In his Washington Post (4/22, 10.52M) column, Fareed Zakaria argues the pause, and Europe's temporary suspension of the AstraZeneca vaccine, "are fueling many people's fears EFTA00150536 about vaccine safety, perpetuating conspiracy theories and wasting precious time at a momen

s, "The fate of the Johnson & Johnson vaccine is scheduled to be discussed publicly in a pivotal meeting Friday of an influential advisory group to the Centers for Disease Control and Prevention." The CBS Evening NewsVi (4/22, lead story, 4:30, O'Donnell, 3.71M) reported that use of the vaccine could resume "as early as" Friday, adding it "